Pharmaceutical Chemistry Faculty
Professor Cory Berkland earned a BS in chemical engineering at Iowa State University, an MS in chemical engineering from the University of Illinois and a PhD in chemical and bimolecular engineering at the University of Illinios. He also completed his post doc work at the University of Illinois.
Distinguished Professor Borchardt's research interests include peptide transport, prodrugs of peptides, blood-brain barrier, intestinal mucosal barrier, cell culture systems, protein and peptide stability.
Professor Brandon DeKosky earned a B.S. in Chemical Engineering from the University of Kansas in 2010 and a Ph.D. in Biochemical Engineering from the University of Texas at Austin in 2015. He completed a Post Doc in Immunology & Vaccinology at the Vaccine Research Center, National Institute of Allergy and Infectious Diseases in Bethesda, MD in 2017.
Associate Professor Laird Forrest earned a BS in chemical engineering from Auburn University and an MS in chemical engineering at the University of Illinois-Urbana. He also earned a PhD in chemical and biomolecular engineering at the University of Illinois-Urbana. He completed a postdoctoral fellowship in pharmaceutical sciences at the University of Wisconsin.
Professor Hageman earned his B.S. in Pharmacy and Ph.D. in Pharmaceutical Chemistry from the University of Kansas. His research experiences have included industrial positions in R&D at Pharmacia, Pfizer and Bristol-Myers Squibb.
Dr. Jeff Krise is currently an associate professor of pharmaceutical chemistry at the University of Kansas. He holds a Bachelor of Science degree in pharmacy from Duquesne University (1993). He earned his PhD (with honors) from the Department of Pharmaceutical Chemistry at the University of Kansas in 1998. Dr. Krise completed one year of his PhD training at the Victorian College of Pharmacy (now Monash University) in Melbourne, Australia. Dr. Krise received postdoctoral training at Stanford University School of Medicine from 1998 to 2001 in the Department of Biochemistry. In 2001 he began his academic career at the University of North Carolina at Chapel Hill in the Division of Drug Delivery and Disposition. In 2004 he moved to back to the University of Kansas in the Department of Pharmaceutical Chemistry.
Distinguished Professor C. Russell Middaugh earned a B.S. from the University of California, Santa Cruz, a Ph.D. from Cornell University and completed his postdoctoral fellowship at the University of Minnesota.
Professor Picking earned her Ph.D. at the University of Kansas. Her research interests are vaccine development - especially for the children of low income countries, Enteric bacterial pathogens, and type III secretion.
Many Gram-negative bacterial pathogens possess a type III secretion system that is responsible for injecting proteins into a host cell to subvert normal host cell processes for the benefit of the pathogen – often to promote invasion of the cell. The injection nanomachine is called the type III secretion apparatus (T3SA) and it resembles a syringe embedded in the bacterial membranes with an external needle and needle tip complex that senses target cell contact. The proteins make up the T3SA are highly conserved among closely related bacteria making them the ideal serotype-independent candidates for broadly protective vaccines. We have developed a subunit vaccine by fusing the Shigella T3SA proteins. We have shown it is protective in mice and non-human primates using a variety of routes and adjuvants. Currently, we are using this same platform to develop a broadly protective vaccine against Salmonella.
Distinguished Professor Picking earned his Ph.D. at the University of Kansas. He is the director of the Kansas Vaccine Development Center and director of the Higuchi Biosciences Center.
Professor Schöneich is the Takeru Higuchi Distinguished Professor and Chair of the Department of Pharmaceutical Chemistry. He earned his diplom in 1987 from the Free University Berlin (Germany) and his Ph.D. in 1990 at the Technical University Berlin (Germany).
Professor Teruna Siahaan earned a B.S. and an M.S. from the University of Indonesia and a Ph.D. from the University of Arizona. He completed a postdoctoral fellowship at the University of California, Santa Barbara.
Associate Dean John Stobaugh earned a B.S. from the University of Oklahoma in 1974, an M.S. from the University of Oklahoma in 1977, and a Ph.D. from the University of Kansas in 1982.
Associate Professor Thomas Tolbert earned a B.S. in chemistry from Purdue University, a Ph.D. in Biochemistry from the Massachusetts institute of Technology and completed his postdoctoral research at the Scripps Research Institute.
Distinguished Professor David Volkin earned a BA in chemistry at the University of California, San Diego and a PhD in Biochemical Engineering at the Massachusetts Institute of Technology in Cambridge, Massachusetts.
Prof. Michael Zhuo Wang completed his PhD in 2003 from Duke University (Durham, North Carolina, USA) and postdoctoral studies from University of North Carolina at Chapel Hill, School of Pharmacy (Chapel Hill, North Carolina, USA). Dr. Wang received his BS in Chemistry in 1998 from Peking University (Beijing, China). He is now an Associate Professor and Assistant Director of Graduate Studies in the Department of Pharmaceutical Chemistry, University of Kansas (Lawrence, Kansas, USA). He has published more than 30 peer-reviewed papers in reputed journals in the fields of analytical chemistry, pharmacology and pharmaceutics, and has served as an Editorial Board Member for several journals.